2016-03-05T00:00:00.000-05:00
personal trading style,0.598412
Exchange Commission,0.281096
research-based biopharmaceutical company,0.642682
average rating,-0.314266
target price,0.316513
Gilead Sciences Inc.,0.555178
dividend yield,0.291332
strong buy rating,0.372237
Gilead Sciences stock,-0.212307
COO John F.,-0.218743
Boston Advisors,0.206719
average price,-0.277062
shares,-0.0307458
investment portfolio,0.427068
executive vice president,0.214786
concise daily summary,0.447788
consensus price target,0.436043
Gilead Sciences,0.117987
stock broker,0.245696
InvestorPlace Broker Center,0.555736
recent Form,0.281096
biopharmaceutical company,0.424701
research report,0.316513
12-month high,-0.491454
chronic hepatitis,-0.646567
EVP Paul Rutherford,-0.205872
quarter,-0.18877
